Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy

par Ilander, Mette, Kreutzman, Anna, Rohon, Peter, Melo, Teresa, Faber, Edgar, Porkka, Kimmo, Vakkila, Jukka, Mustjoki, Satu
Publié 2014

Operational Cures After Interferon-Alpha in Patients with Chronic Myeloid Leukemia in Central and Northern Moravia

par Faber, Edgar, Kuba, Adam, Zapletalová, Jana, Divoká, Martina, Rožmanová, Šárka, Rohoň, Peter, Holzerová, Milena, Jarošová, Marie, Indrák on Behalf of Cooperating Group, Karel
Publié 2012

COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic

par Čerňan, Martin, Szotkowski, Tomáš, Obr, Aleš, Látal, Vojtěch, Hluší, Antonín, Krhovská, Petra, Klementová, Olga, Kolář, Milan, Sauer, Pavel, Faber, Edgar, Fürst, Tomáš, Papajík, Tomáš
Publié dans Clin Lymphoma Myeloma Leuk (2021)

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in Hi...

par Polivkova, Vaclava, Rohon, Peter, Klamova, Hana, Cerna, Olga, Divoka, Martina, Curik, Nikola, Zach, Jan, Novak, Martin, Marinov, Iuri, Soverini, Simona, Faber, Edgar, Machova Polakova, Katerina
Publié dans PLoS One (2016)

Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

par Kreutzman, Anna, Rohon, Peter, Faber, Edgar, Indrak, Karel, Juvonen, Vesa, Kairisto, Veli, Voglová, Jaroslava, Sinisalo, Marjatta, Flochová, Emília, Vakkila, Jukka, Arstila, Petteri, Porkka, Kimmo, Mustjoki, Satu
Publié 2011

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels

par Klamová, Hana, Poláková, Kateřina Machová, Mužík, Jan, Ráčil, Zdeněk, Žáčková, Daniela, Steinerová, Kateřina, Karas, Michal, Faber, Edgar, Demečková, Eva, Michalovičová-Sninská, Zuzana, Voglová, Jaroslava, Demitrovičová, Ľudmila, Mikušková, Eva, Tóthová, Elena, Chudej, Juraj, Markuljak, Imrich, Cmunt, Eduard, Moravcová, Jana, Dvořáková, Dana, Michalová, Kyra, Jarošová, Marie, Šťastná, Markéta Marková, Cetkovský, Petr, DuŠek, Ladislav, Koza, Vladimír, Trněný, Marek, Indrák, Karel
Publié 2013

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

par Pfirrmann, Markus, Clark, Richard E., Prejzner, Witold, Lauseker, Michael, Baccarani, Michele, Saussele, Susanne, Guilhot, François, Heibl, Sonja, Hehlmann, Rüdiger, Faber, Edgar, Turkina, Anna, Ossenkoppele, Gert, Höglund, Martin, Zaritskey, Andrey, Griskevicius, Laimonas, Olsson-Strömberg, Ulla, Everaus, Hele, Koskenvesa, Perttu, Labar, Boris, Sacha, Tomasz, Zackova, Daniela, Cervantes, Francisco, Colita, Adriana, Zupan, Irena, Bogdanovic, Andrija, Castagnetti, Fausto, Guilhot, Joëlle, Hasford, Joerg, Hochhaus, Andreas, Hoffmann, Verena S.
Publié dans Leukemia (2020)

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

par Cuesta-Mateos, Carlos, Fuentes, Patricia, Schrader, Alexandra, Juárez-Sánchez, Raquel, Loscertales, Javier, Mateu-Albero, Tamara, Vega-Piris, Lorena, Espartero-Santos, Marina, Marcos-Jimenez, Ana, Sánchez-López, Blanca Andrea, Pérez-García, Yaiza, Jungherz, Dennis, Oberbeck, Sebastian, Wahnschaffe, Linus, Kreutzman, Anna, Andersson, Emma I., Mustjoki, Satu, Faber, Edgar, Urzainqui, Ana, Fresno, Manuel, Stamatakis, Kostantino, Alfranca, Arantzazu, Terrón, Fernando, Herling, Marco, Toribio, María Luisa, Muñoz-Calleja, Cecilia
Publié dans Biomark Res (2020)